ATOPIC DERMATITIS (AD)

This study is testing whether an experimental tablet called HSK44459 can improve skin symptoms and reduce itching in adults with moderate-to-severe atopic dermatitis (eczema). Researchers will compare two different doses of the pill against a placebo (inactive pill) over 12 weeks…

This is an early safety study testing a new oral medication called ENV-294 for adults with moderate-to-severe atopic dermatitis (eczema). The main goal is to see if the drug is safe and well-tolerated when taken daily for 28 days. Researchers will also check if it helps reduce ec…

This study is testing whether an oral tablet called QY201 can help adults with moderate to severe atopic dermatitis, also known as eczema. Researchers will compare the pill to a placebo (a dummy pill) to see if it reduces skin inflammation and itching over 16 weeks. The trial is …

This is an early-stage study to check if a new drug called ATTO1310 is safe for people and how long it stays in the body. It will involve 108 healthy adults and people with atopic dermatitis (eczema) or chronic itching. Researchers will compare the drug to a placebo to see if it …

This is the first-ever study in humans of a new drug called GB-7624, which is being developed for atopic dermatitis (eczema). The main goal is to check if the drug is safe and how the body processes it. The study will enroll 40 healthy adult volunteers to receive either the drug …